Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Pentane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 5/20 | 0.40 |
| ▸ | CES1 | P23141 | 5/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL27124389 | 0.93 | RECQL (0.56) | TSHRRECQLHPGDMAPK1GLA | |
| Tetradecane SCHEMBL3394343 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Sulfuric Acid SCHEMBL29238029 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Decane SCHEMBL3962532 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Tetradecane SCHEMBL2679723 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Heptane SCHEMBL25268199 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Pentadecane SCHEMBL13370387 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Octane SCHEMBL7174098 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Dodecane SCHEMBL5903124 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA | |
| Sulfuric Acid SCHEMBL29027387 | 0.90 | RECQL (0.61) | TSHRRECQLHPGDMAPK1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200390710-A1 | Method for the Production of Commercial Nanoparticle and Microparticle Powders | ICEUTICA PTY LTD. (AU) | 2020-12-17 | — | — | US | claimed |
| EP-2421510-B1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE | ICEUTICA PTY LTD (AU) | 2019-07-31 | — | — | EP | claimed |
| US-20180251433-A1 | Novel formulation of metaxalone | ICEUTICA PTY LTD. (AU) | 2018-09-06 | — | — | US | claimed |
| US-20180243707-A1 | Production of encapsulated nanoparticles at high volume fractions | ICEUTICA PTY LTD. (AU) | 2018-08-30 | — | — | US | claimed |
| US-20180194759-A1 | NOVEL FORMULATION OF MELOXICAM | ICEUTICA PTY LTD. (AU) | 2018-07-12 | — | — | US | claimed |
| US-20170165203-A1 | Method for the Production of Commercial Nanoparticle and Microparticle Powders | ICEUTICA PTY LTD. | 2017-06-15 | — | — | US | claimed |
| US-20170100356-A1 | NOVEL FORMULATION OF DICLOFENAC | ICEUTICA PTY LTD. | 2017-04-13 | — | — | US | claimed |
| CN-105663045-A | Production of encapsulated nanoparticles at high volume fractions | 伊休蒂卡有限公司 | 2016-06-15 | — | — | CN | claimed |
| US-20160108009-A1 | Novel formulation of metaxalone | ICEUTICA PTY LTD. | 2016-04-21 | — | — | US | claimed |
| US-20160102086-A1 | NOVEL FORMULATION OF MELOXICAM | EMC CORPORATION (ON BEHALF OF ITSELF AND AS SUCCESSOR-IN-INTEREST TO MAGINATICS LLC) | 2016-04-14 | — | — | US | claimed |
| EP-2421530-A1 | A NOVEL FORMULATION OF METAXALONE | Iceutica Pty Ltd. (AU) | 2012-02-29 | — | — | EP | claimed |
| WO-2010121328-A1 | A NOVEL FORMULATION OF INDOMETHACIN | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121327-A1 | A NOVEL FORMULATION OF DICLOFENAC | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121326-A1 | A NOVEL FORMULATION OF NAPROXEN | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121325-A1 | A NOVEL FORMULATION OF MELOXICAM | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121324-A1 | A NOVEL FORMULATION OF METAXALONE | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121320-A1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT HIGH VOLUME FRACTIONS | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121321-A1 | METHOD FOR IMPROVING THE DISSOLUTION PROFILE OF A BIOLOGICALLY ACTIVE MATERIAL | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121323-A1 | METHOD FOR THE PRODUCTION OF COMMERCIAL NANOPARTICLE AND MICROPARTICLE POWDERS | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |
| WO-2010121322-A1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | claimed |